Literature DB >> 14529777

The value of a positive margin for invasive carcinoma in breast-conservative treatment in relation to local recurrence is limited to young women only.

Jan J Jobsen1, Job van der Palen, Francisca Ong, Jacobus H Meerwaldt.   

Abstract

PURPOSE: To identify the importance of positive margins for invasive carcinoma on local control in patients treated with breast-conservative treatment (BCT). METHODS AND MATERIALS: A total of 1752 BCT with known margins were analyzed. Fifty-five patients had a second BCT, leaving 1697 patients for analysis. The margins were positive in 193/1752 BCT (11%). The median follow-up was 78 months.
RESULTS: The 5- and 10-year local recurrence rates (LRR) were 3.1% and 6.9%, respectively, for negative margins vs. 5.6% and 12.2% for positive margins. A statistical interaction between age category and margin status was noted in relation to disease-free survival (DFS) and local relapse-free survival. The 5-year LRR for women < or =40 years was 8.4% for negative margins and 36.9% for positive margins (p = 0.005). In a multivariate analysis, a positive margin was significant. The 5-year LRR for women >40 years was 2.6% for negative and 2.2% for positive margins. The 5-year DFS for women </=40 years was 27.4% for positive and 74.5% for negative margins (p = 0.001). The 5-year DFS for women >40 years was 84.3% for positive and 87.2% for negative margins.
CONCLUSION: Women < or =40 years are a special category of patients in breast cancer. Women < or =40 years must have negative margins for invasive carcinoma when treated with BCT. Minimum surgery for an optimal cosmetic result followed by irradiation, even with microscopic positive margins for invasive carcinoma, yields excellent results with regard to local control in patients older than 40 years.

Entities:  

Mesh:

Year:  2003        PMID: 14529777     DOI: 10.1016/s0360-3016(03)00644-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  13 in total

1.  Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy.

Authors:  Jona A Hattangadi-Gluth; Jennifer Y Wo; Paul L Nguyen; Rita F Abi Raad; Meera Sreedhara; Andrzej Niemierko; Phoebe E Freer; Dianne Georgian-Smith; Jennifer R Bellon; Julia S Wong; Barbara L Smith; Jay R Harris; Alphonse G Taghian
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-19       Impact factor: 7.038

Review 2.  Comparison of recurrence and survival rates after breast-conserving therapy and mastectomy in young women with breast cancer.

Authors:  J Q Cao; R A Olson; S K Tyldesley
Journal:  Curr Oncol       Date:  2013-12       Impact factor: 3.677

3.  Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy.

Authors:  Nils D Arvold; Alphonse G Taghian; Andrzej Niemierko; Rita F Abi Raad; Meera Sreedhara; Paul L Nguyen; Jennifer R Bellon; Julia S Wong; Barbara L Smith; Jay R Harris
Journal:  J Clin Oncol       Date:  2011-09-06       Impact factor: 44.544

4.  Positive margin rates following breast-conserving surgery for stage I-III breast cancer: palpable versus nonpalpable tumors.

Authors:  Jordan Atkins; Fatema Al Mushawah; Catherine M Appleton; Amy E Cyr; William E Gillanders; Rebecca L Aft; Timothy J Eberlein; Feng Gao; Julie A Margenthaler
Journal:  J Surg Res       Date:  2012-04-10       Impact factor: 2.192

5.  Ipsilateral breast tumor recurrence after breast-conserving therapy: A comparison of quadrantectomy versus lumpectomy at a single institution.

Authors:  Woo Chul Noh; Nam Sun Paik; Min Suk Kim; Kwang Mo Yang; Chul Koo Cho; Dong Wook Choi; Jong Inn Lee; Sung Ku Kang; Sang Bum Kim; Nan Mo Moon
Journal:  World J Surg       Date:  2005-08       Impact factor: 3.352

6.  Breast cancer in moroccan young women: a retrospective study.

Authors:  Halima Abahssain; Issam Lalya; Fatima Zahra El M'rabet; Nabil Ismaili; Rachid Razine; Mohammed Adnane Tazi; Hind M'rabti; Omar El Mesbahi; Nourddine Benjaafar; Redouane Abouqal; Hassan Errihani
Journal:  BMC Res Notes       Date:  2010-11-08

Review 7.  Intraoperative Electron Radiotherapy (IOERT) as an Alternative to Standard Whole Breast Irradiation: Only for Low-Risk Subgroups?

Authors:  Sergio Maluta; Stefano Dall'Oglio; Donald A Goer; Nadia Marciai
Journal:  Breast Care (Basel)       Date:  2014-05       Impact factor: 2.860

8.  Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.

Authors:  Heather A Jones; Ninja Antonini; Augustinus A M Hart; Johannes L Peterse; Jean-Claude Horiot; Françoise Collin; Philip M Poortmans; S Bing Oei; Laurence Collette; Henk Struikmans; Walter F Van den Bogaert; Alain Fourquet; Jos J Jager; Dominic A X Schinagl; Carla C Wárlám-Rodenhuis; Harry Bartelink
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

9.  Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma.

Authors:  Fabien Reyal; David Hajage; Alexia Savignoni; Jean-Guillaume Feron; Marc Andrew Bollet; Youlia Kirova; Alain Fourquet; Jean-Yves Pierga; Paul Cottu; Veronique Dieras; Virginie Fourchotte; Fatima Laki; Severine Alran; Bernard Asselain; Anne Vincent-Salomon; Brigitte Sigal-Zafrani; Xavier Sastre-Garau
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

10.  Timing of radiotherapy in breast-conserving therapy: a large prospective cohort study of node-negative breast cancer patients without adjuvant systemic therapy.

Authors:  J J Jobsen; J van der Palen; M Baum; M Brinkhuis; H Struikmans
Journal:  Br J Cancer       Date:  2013-02-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.